210 related articles for article (PubMed ID: 38504436)
21. JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China.
Chen M; Ma L; Yu H; Huang S; Zhang J; Gong J; Yang L; Chen L; Luo H; Tian L; Wang S
Front Oncol; 2023; 13():1155592. PubMed ID: 37601658
[TBL] [Abstract][Full Text] [Related]
22. Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.
Yang XB; Wu WY; Long SQ; Deng H; Pan ZQ; He WF; Zhou YS; Liao GY; Li QP; Xiao SJ; Cai JZ
Trials; 2015 Apr; 16():146. PubMed ID: 25873045
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of Jianpishengsui for chemotherapy-related fatigue in patients with non-small cell lung cancer: study protocol for a randomized placebo-controlled clinical trial.
Xiao Z; Hu L; Lin J; Lu L; Huang X; Zhu X; Teo C; Lin L
Trials; 2020 Jan; 21(1):94. PubMed ID: 31948475
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota modulation and anti-inflammatory properties of Xuanbai Chengqi decoction in septic rats.
Mu S; Zhang J; Du S; Zhu M; Wei W; Xiang J; Wang J; Han Y; Zhao Y; Zheng H; Tong C; Song Z
J Ethnopharmacol; 2021 Mar; 267():113534. PubMed ID: 33137434
[TBL] [Abstract][Full Text] [Related]
25. Drug-polysaccharide/herb interactions and compatibility rationality of Sijunzi decoction based on comprehensive pharmacokinetic screening for multi-components in rats with spleen deficiency syndrome.
Dong B; Ma P; Chen X; Peng Y; Peng C; Li X
J Ethnopharmacol; 2023 Feb; 302(Pt A):115871. PubMed ID: 36309112
[TBL] [Abstract][Full Text] [Related]
26. Effect of Feitai Capsule () on quality of life and progression-free survival of patients with unresectable non-small cell lung cancer.
Yu ZY; Liu ZZ; Ouyang XN; Du J; Dai XH; Chen X; Zhao ZQ; Wang WW; Li J
Chin J Integr Med; 2012 Feb; 18(2):106-11. PubMed ID: 22311406
[TBL] [Abstract][Full Text] [Related]
27. Effect of Wuye Decoction on lymphocyte phenotype in patients with non-small cell lung cancer.
Zheng SL; Yang QS; Ma XH
Chin J Integr Med; 2006 Jun; 12(2):118-21. PubMed ID: 16800990
[TBL] [Abstract][Full Text] [Related]
28. Modulation of cellular metabolism and alleviation of bacterial dysbiosis by Aconiti Lateralis Radix Praeparata in non-small cell lung cancer treatment.
Zhang W; Ding M; Feng Y; Cai S; Luo Z; Shan J; Di L
Phytomedicine; 2024 Apr; 126():155099. PubMed ID: 38412665
[TBL] [Abstract][Full Text] [Related]
29. Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments.
Peng H; Huang Z; Li P; Sun Z; Hou X; Li Z; Sang R; Guo Z; Wu S; Cao Y
J Ethnopharmacol; 2024 Mar; 321():117518. PubMed ID: 38042385
[TBL] [Abstract][Full Text] [Related]
30. Effects of Si-Jun-Zi decoction polysaccharides on cell migration and gene expression in wounded rat intestinal epithelial cells.
Liu L; Han L; Wong DY; Yue PY; Ha WY; Hu YH; Wang PX; Wong RN
Br J Nutr; 2005 Jan; 93(1):21-9. PubMed ID: 15705221
[TBL] [Abstract][Full Text] [Related]
31. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
32. [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial].
Yan GY; Xu ZY; Deng HB; Wan ZY; Zhang L; Zhu JY
Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):525-30. PubMed ID: 21565138
[TBL] [Abstract][Full Text] [Related]
33. [Assessment of therapeutic efficacy on treating advanced non-small cell lung cancer in the aged by Chinese medicine adopting the international questionnaire of quality of life].
Shan MJ; Han BH; You J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jul; 31(7):873-9. PubMed ID: 21866652
[TBL] [Abstract][Full Text] [Related]
34. Gegen Qinlian decoction enhances immunity and protects intestinal barrier function in colorectal cancer patients
Li Y; Li ZX; Xie CY; Fan J; Lv J; Xu XJ; Lv J; Kuai WT; Jia YT
World J Gastroenterol; 2020 Dec; 26(48):7633-7651. PubMed ID: 33505141
[TBL] [Abstract][Full Text] [Related]
35. Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis.
Lu H; Gao NL; Tong F; Wang J; Li H; Zhang R; Ma H; Yang N; Zhang Y; Wang Y; Liang Z; Zeng H; Chen WH; Dong X
Microbiol Spectr; 2021 Dec; 9(3):e0080221. PubMed ID: 34787462
[TBL] [Abstract][Full Text] [Related]
36. The use of a standardized Chinese herbal formula in patients with advanced lung cancer: a feasibility study.
Kasymjanova G; Tran AT; Cohen V; Pepe C; Sakr L; Small D; Agulnik JS; Jagoe RT
J Integr Med; 2018 Nov; 16(6):390-395. PubMed ID: 30292672
[TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy and safety of NSCLC ancillary treatment with compound Kushen injection through immunocompetence regulation: A systematic review and meta-analysis.
Wang D; Xu Y; Huang T; Peng W; Zhu D; Zhou X; Wu Q
Phytomedicine; 2022 Sep; 104():154315. PubMed ID: 35868145
[TBL] [Abstract][Full Text] [Related]
38. Modified Sijunzi decoction in the treatment of ulcerative colitis in the remission phase: study protocol for a series of N-of-1 double-blind, randomised controlled trials.
Chen YM; Deng JM; Wen Y; Chen B; Hou JT; Peng B; Zhang SJ; Mi H; Jiang QL; Wu XL; Liu FB; Chen XL
Trials; 2020 May; 21(1):396. PubMed ID: 32398112
[TBL] [Abstract][Full Text] [Related]
39. Investigating efficacy of "microbiota modulation of the gut-lung Axis" combined with chemotherapy in patients with advanced NSCLC: study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial.
Xia Q; Chen G; Ren Y; Zheng T; Shen C; Li M; Chen X; Zhai H; Li Z; Xu J; Gu A; Jin M; Fan L
BMC Cancer; 2021 Jun; 21(1):721. PubMed ID: 34157996
[TBL] [Abstract][Full Text] [Related]
40. Bu-Fei decoction and modified Bu-Fei decoction inhibit the growth of non-small cell lung cancer, possibly via inhibition of apurinic/apyrimidinic endonuclease 1.
Jiang ST; Han SY; Pang LN; Jiao YN; He XR; Li PP
Int J Mol Med; 2018 Apr; 41(4):2128-2138. PubMed ID: 29393411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
